<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03570606</url>
  </required_header>
  <id_info>
    <org_study_id>ROSA01</org_study_id>
    <nct_id>NCT03570606</nct_id>
  </id_info>
  <brief_title>Clinical Study of Bone Graft Substitutes in Orthopaedic and Spinal Applications.</brief_title>
  <acronym>ROSA</acronym>
  <official_title>A Multi-centred, Post-market Clinical Follow-up Study of Synthetic Bone Graft Substitutes for Use in Orthopaedic and Spinal Applications.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ceramisys Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ceramisys Ltd</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational, prospective, non-randomised, multi-centred post market clinical
      follow-up study to compile real world clinical data on safety and efficacy of the synthetic
      bone graft substitutes in a commercial clinical setting in long bone and extremity defects
      and in spinal fusion procedures.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 13, 2019</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Anticipated">August 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Primary endpoints will be successful radiographic bone repair.</measure>
    <time_frame>12 months</time_frame>
    <description>Bone formation and material resorption, observable by x-ray/MRI</description>
  </primary_outcome>
  <number_of_groups>7</number_of_groups>
  <enrollment type="Anticipated">175</enrollment>
  <condition>Bone Deformity</condition>
  <arm_group>
    <arm_group_label>HA Paste in Spine</arm_group_label>
    <description>Evaluation of HA Paste in spinal fusion procedures
o Spinal cage filling</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HA Paste in long bone &amp; extremities</arm_group_label>
    <description>Evaluation of HA Paste in long bone and extremity group:
Filling bone defects after cyst removal
Filling distal radius fractures
Filling defects such as tibial plateau fractures
Filling defects created by osteotomy procedures</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Granulated Paste in Spine</arm_group_label>
    <description>Evaluation of Granulated Paste in spinal fusion procedures
o Spinal cage filling</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Granulated Paste in long bone &amp; extremities</arm_group_label>
    <description>Evaluation of Granulated Paste in long bone and extremity group:
Filling bone defects after cyst removal
Filling distal radius fractures
Filling defects such as tibial plateau fractures
Filling defects created by osteotomy procedures</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Granules in Spine</arm_group_label>
    <description>Evaluation of Granules in spinal fusion procedures
o Spinal cage filling</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Granules in long bone &amp; extremities</arm_group_label>
    <description>Evaluation of Granules in long bone and extremity group:
Filling bone defects after cyst removal
Filling distal radius fractures
Filling defects such as tibial plateau fractures
Filling defects created by osteotomy procedures</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Block in long bone &amp; extremities</arm_group_label>
    <description>Evaluation of Blocks in long bone and extremity group:
o High tibial osteotomies with fixation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>bone graft substitute</intervention_name>
    <description>orthopaedic or spine bony defects</description>
    <arm_group_label>Block in long bone &amp; extremities</arm_group_label>
    <arm_group_label>Granulated Paste in Spine</arm_group_label>
    <arm_group_label>Granulated Paste in long bone &amp; extremities</arm_group_label>
    <arm_group_label>Granules in Spine</arm_group_label>
    <arm_group_label>Granules in long bone &amp; extremities</arm_group_label>
    <arm_group_label>HA Paste in Spine</arm_group_label>
    <arm_group_label>HA Paste in long bone &amp; extremities</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        male or female 18-80 meeting the inclusion criteria, provided no exclusion criteria are
        met:
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Long Bone and Extremity Indications: patients requiring bone grafting after post-traumatic
        or surgically created bone defects afflicting the long bones and extremities.

        Spine Indication: patients with degenerative disc disease or trauma who require spinal
        fusion of 1 or more vertebral bodies and where conservative treatment has been
        unsuccessful.

        Patients who are willing and capable of providing informed consent, participating in all
        testing associated with this clinical investigation at an approved clinical investigational
        center;

        Exclusion Criteria:

        Patients who are currently enrolled in another investigational study or registry that would
        directly interfere with the current study, except when the patient is participating in a
        mandatory governmental registry, or a purely observational registry with no associated
        treatments. Each instance should be brought to the attention of the sponsor to determine
        eligibility.

        Women of childbearing potential who are, or plan to become, pregnant during the time of the
        study (method of assessment upon physician's discretion); The subject is unable or not
        willing to complete follow-up visits and examination for the duration of the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Rebecca Hutchinson</last_name>
    <phone>+441142327070</phone>
    <email>b.hutchinson@ceramisys.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Doncaster &amp; Bassetlaw Teaching Hospitals NHS Foundation Trust</name>
      <address>
        <city>Doncaster</city>
        <state>South Yorkshire</state>
        <zip>DN2 5LT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sanjeev Madan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northumbria Healthcare NHS Foundation Trust</name>
      <address>
        <city>North Shields</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Salford Royal NHS Foundation Trust</name>
      <address>
        <city>Salford</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospitals of North Midlands NHS Trust</name>
      <address>
        <city>Stoke-on-Trent</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Taunton and Somerset NHS Foundation Trust</name>
      <address>
        <city>Taunton</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>June 18, 2018</study_first_submitted>
  <study_first_submitted_qc>June 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 27, 2018</study_first_posted>
  <last_update_submitted>August 1, 2019</last_update_submitted>
  <last_update_submitted_qc>August 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Congenital Abnormalities</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

